Shares of Becton, Dickinson and Company closed at $188.90 on October 13, 2026, marking a 2.80% gain for the session. The medical technology company, which trades on major exchanges under the ticker BDX, carried a market capitalization of $50.05 billion at that price.
The single-session advance was part of a broader upward trend for the stock. Over the prior seven days, BDX gained 4.55%, and over the trailing 30-day period, shares rose 6.23%, reflecting consistent positive momentum across near-term timeframes.
The 30-day performance of 6.23% represents the strongest gain among the measured periods, suggesting the stock's upward movement has been building over the course of the past month. The session's close at $188.90 represents the latest data point in that trend.
Becton, Dickinson is a global medical technology company with operations spanning diagnostics, medication management, and related health care solutions. With a market capitalization of $50.05 billion, it remains among the larger companies in the medical devices and equipment sector.
